Edaravone, a free radical scavenger, ameliorates experimental autoimmune encephalomyelitis

Neuroscience Letters

Volumn 440, Issue 3, 2008, Pages 323-326

  Moriya, Masayuki ^a   Nakatsuji, Yuji ^a   Miyamoto, Katsuichi ^b   Okuno, Tatsusada ^a,c   Kinoshita, Makoto ^a   Kumanogoh, Atsushi ^c   Kusunoki, Susumu ^b   Sakoda, Saburo ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c OSAKA UNIVERSITY   (Japan)

Author keywords

Experimental autoimmune encephalomyelitis; Free radical scavenger; Inducible NO synthase; Multiple sclerosis; Reactive oxygen species

Indexed keywords

INDUCIBLE NITRIC OXIDE SYNTHASE; NORPHENAZONE; REACTIVE OXYGEN METABOLITE;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; FEMALE; IN VITRO STUDY; LYMPHOCYTIC INFILTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; ANTIGENS, CD3; ANTIPYRINE; CALCIUM-BINDING PROTEINS; CELL LINE, TRANSFORMED; DISEASE MODELS, ANIMAL; DOWN-REGULATION; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; FREE RADICAL SCAVENGERS; MICE; MICROGLIA; NITRIC OXIDE SYNTHASE TYPE II; SPINAL CORD; STATISTICS, NONPARAMETRIC;

EID: 45849118287     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2008.05.110     Document Type: Article

References (28)

1. Abe K., Yuki S., and Kogure K. Strong attenuation of ischemic and postischemic brain edema in rats by a novel free radical scavenger. Stroke 19 (1988) 480-485
2. Aboul-Enein F., Weiser P., Hoftberger R., Lassmann H., and Bradl M. Transient axonal injury in the absence of demyelination: a correlate of clinical disease in acute experimental autoimmune encephalomyelitis. Acta Neuropathol. (Berl). 111 (2006) 539-547
3. Banno M., Mizuno T., Kato H., Zhang G., Kawanokuchi J., Wang J., Kuno R., Jin S., Takeuchi H., and Suzumura A. The radical scavenger edaravone prevents oxidative neurotoxicity induced by peroxynitrite and activated microglia. Neuropharmacology 48 (2005) 283-290
4. Chaudhary P., Marracci G.H., and Bourdette D.N. Lipoic acid inhibits expression of ICAM-1 and VCAM-1 by CNS endothelial cells and T cell migration into the spinal cord in experimental autoimmune encephalomyelitis. J. Neuroimmunol. 175 (2006) 87-96
5. Cross A.H., Misko T.P., Lin R.F., Hickey W.F., Trotter J.L., and Tilton R.G. Aminoguanidine, an inhibitor of inducible nitric oxide synthase, ameliorates experimental autoimmune encephalomyelitis in SJL mice. J. Clin. Invest. 93 (1994) 2684-2690
6. Ding M., Zhang M., Wong J.L., Rogers N.E., Ignarro L.J., and Voskuhl R.R. Antisense knockdown of inducible nitric oxide synthase inhibits induction of experimental autoimmune encephalomyelitis in SJL/J mice. J. Immunol. 160 (1998) 2560-2564
7. Gilgun-Sherki Y., Melamed E., and Offen D. The role of oxidative stress in the pathogenesis of multiple sclerosis: the need for effective antioxidant therapy. J. Neurol. 251 (2004) 261-268
8. Greco A., Minghetti L., Sette G., Fieschi C., and Levi G. Cerebrospinal fluid isoprostane shows oxidative stress in patients with multiple sclerosis. Neurology 53 (1999) 1876-1879
9. Hendriks J.J., Alblas J., van der Pol S.M., van Tol E.A., Dijkstra C.D., and de Vries H.E. Flavonoids influence monocytic GTPase activity and are protective in experimental allergic encephalitis. J. Exp. Med. 200 (2004) 1667-1672
10. Hooper D.C., Bagasra O., Marini J.C., Zborek A., Ohnishi S.T., Kean R., Champion J.M., Sarker A.B., Bobroski L., Farber J.L., Akaike T., Maeda H., and Koprowski H. Prevention of experimental allergic encephalomyelitis by targeting nitric oxide and peroxynitrite: implications for the treatment of multiple sclerosis. Proc. Natl. Acad. Sci. U.S.A. 94 (1997) 2528-2533
11. Ikeda T., Xia Y.X., Kaneko M., Sameshima H., and Ikenoue T. Effect of the free radical scavenger, 3-methyl-1-phenyl-2-pyrazolin-5-one (MCI-186), on hypoxia-ischemia-induced brain injury in neonatal rats. Neurosci. Lett. 329 (2002) 33-36
12. Kanzawa T., Sawada M., Kato K., Yamamoto K., Mori H., and Tanaka R. Differentiated regulation of allo-antigen presentation by different types of murine microglial cell lines. J. Neurosci. Res. 62 (2000) 383-388
13. Kawai H., Nakai H., Suga M., Yuki S., Watanabe T., and Saito K.I. Effects of a novel free radical scavenger, MCl-186, on ischemic brain damage in the rat distal middle cerebral artery occlusion model. J. Pharmacol. Exp. Ther. 281 (1997) 921-927
14. Koprowski H., Zheng Y.M., Heber-Katz E., Fraser N., Rorke L., Fu Z.F., Hanlon C., and Dietzschold B. In vivo expression of inducible nitric oxide synthase in experimentally induced neurologic diseases. Proc. Natl. Acad. Sci. U.S.A. 90 (1993) 3024-3027
15. LeVine S.M. The role of reactive oxygen species in the pathogenesis of multiple sclerosis. Med. Hypotheses 39 (1992) 271-274
16. Marracci G.H., Jones R.E., McKeon G.P., and Bourdette D.N. Alpha lipoic acid inhibits T cell migration into the spinal cord and suppresses and treats experimental autoimmune encephalomyelitis. J. Neuroimmunol. 131 (2002) 104-114
17. Marracci G.H., McKeon G.P., Marquardt W.E., Winter R.W., Riscoe M.K., and Bourdette D.N. Alpha lipoic acid inhibits human T-cell migration: implications for multiple sclerosis. J. Neurosci. Res. 78 (2004) 362-370
18. Moriya M., Nakatsuji Y., Okuno T., Hamasaki T., Sawada M., and Sakoda S. Vitamin K2 ameliorates experimental autoimmune encephalomyelitis in Lewis rats. J. Neuroimmunol. 170 (2005) 11-20
19. Offen D., Gilgun-Sherki Y., Barhum Y., Benhar M., Grinberg L., Reich R., Melamed E., and Atlas D. A low molecular weight copper chelator crosses the blood-brain barrier and attenuates experimental autoimmune encephalomyelitis. J. Neurochem. 89 (2004) 1241-1251
20. Pedchenko T.V., and LeVine S.M. Desferrioxamine suppresses experimental allergic encephalomyelitis induced by MBP in SJL mice. J. Neuroimmunol. 84 (1998) 188-197
21. Schreibelt G., Musters R.J., Reijerkerk A., de Groot L.R., van der Pol S.M., Hendrikx E.M., Dopp E.D., Dijkstra C.D., Drukarch B., and de Vries H.E. Lipoic acid affects cellular migration into the central nervous system and stabilizes blood-brain barrier integrity. J. Immunol. 177 (2006) 2630-2637
22. Shichinohe H., Kuroda S., Yasuda H., Ishikawa T., Iwai M., Horiuchi M., and Iwasaki Y. Neuroprotective effects of the free radical scavenger Edaravone (MCI-186) in mice permanent focal brain ischemia. Brain Res. 1029 (2004) 200-206
23. Smith K.J., and Lassmann H. The role of nitric oxide in multiple sclerosis. Lancet Neurol. 1 (2002) 232-241
24. Spitsin S.V., Scott G.S., Kean R.B., Mikheeva T., and Hooper D.C. Protection of myelin basic protein immunized mice from free-radical mediated inflammatory cell invasion of the central nervous system by the natural peroxynitrite scavenger uric acid. Neurosci. Lett. 292 (2000) 137-141
25. Suzuki Y.J., Aggarwal B.B., and Packer L. Alpha-lipoic acid is a potent inhibitor of NF-kappa B activation in human T cells. Biochem. Biophys. Res. Commun. 189 (1992) 1709-1715
26. Zamvil S.S., and Steinman L. The T lymphocyte in experimental allergic encephalomyelitis. Annu. Rev. Immunol. 8 (1990) 579-621
27. Zhang N., Komine-Kobayashi M., Tanaka R., Liu M., Mizuno Y., and Urabe T. Edaravone reduces early accumulation of oxidative products and sequential inflammatory responses after transient focal ischemia in mice brain. Stroke 36 (2005) 2220-2225
28. Zhang W., Sato K., Hayashi T., Omori N., Nagano I., Kato S., Horiuchi S., and Abe K. Extension of ischemic therapeutic time window by a free radical scavenger, edaravone, reperfused with tPA in rat brain. Neurol. Res. 26 (2004) 342-348